These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 16272809)
1. [Examination of rheumatoid factor and other serum markers in rheumatoid arthritis]. Hiura K; Iwaki-Egawa S; Matsuno H; Watanabe Y Yakugaku Zasshi; 2005 Nov; 125(11):881-7. PubMed ID: 16272809 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Ateş A; Karaaslan Y; Aksaray S Clin Rheumatol; 2007 Apr; 26(4):499-504. PubMed ID: 16670828 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Nishimura K; Sugiyama D; Kogata Y; Tsuji G; Nakazawa T; Kawano S; Saigo K; Morinobu A; Koshiba M; Kuntz KM; Kamae I; Kumagai S Ann Intern Med; 2007 Jun; 146(11):797-808. PubMed ID: 17548411 [TBL] [Abstract][Full Text] [Related]
5. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Agrawal S; Misra R; Aggarwal A Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis. Chang PY; Yang CT; Cheng CH; Yu KH Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989 [TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis. Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964 [TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525 [TBL] [Abstract][Full Text] [Related]
15. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients. Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462 [TBL] [Abstract][Full Text] [Related]
16. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years. da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055 [TBL] [Abstract][Full Text] [Related]
18. [Topics on immunological tests for rheumatoid arthritis]. Kumagai S; Nishimura K; Hayashi N Rinsho Byori; 2004 Oct; 52(10):836-43. PubMed ID: 15624500 [TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity. Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]